PAR
Click for more information
0.00% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-117

  1. Gan_Gans
    2,144 Posts.
    lightbulb Created with Sketch. 576
    clock Created with Sketch.
    19/09/19
    21:35
    Post #: 40486916
    Paradigmers: thoughts on Gilead’s drug acquired from Galapagos currently in P2 trials?

    https://clinicaltrials.gov/ct2/show/NCT03595618
    PAR Price at posting: $2.10 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Deep drilling at Mulga Bill confirms gold to 500m depth, indicating further exploration potential
right-arrow Created with Sketch.
NEWS Most viewed thread today: $10m institution led raise to accelerate and expand drilling
right-arrow Created with Sketch.
NEWS High Fe grades identified at Stonehut magnetite prospect, with rock-chip sampling returning over 41% Fe across a 2km strike
right-arrow Created with Sketch.
NEWS High-resolution magnetics at Bunker Hill reveal significant geological structures, aligning with high-grade copper, gold, and silver sample results
right-arrow Created with Sketch.
NEWS Significant copper-gold mineralisation confirmed in initial drilling, highlighting high-grade breccia zones and broad disseminated sulphides, with assays pending
right-arrow Created with Sketch.
NEWS Burmeister achieves outstanding lithium concentrate with simple DMS processing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $70.04M
Open High Low Value Volume
20.5¢ 20.5¢ 19.5¢ $85.57K 427.4K

Buyers (Bids)

No. Vol. Price($)
18 249283 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 84793 7
View Market Depth
Last trade - 15.07pm 16/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.